Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib-Response

Clin Cancer Res. 2015 Dec 15;21(24):5640-1. doi: 10.1158/1078-0432.CCR-15-2298.

¹ Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
² Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Thyroid Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
³ Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. lwirth@partners.org.

No abstract available

Publication types